Peptide Record

Tirzepatide · full corpus

Explore

Every evidence record, mention, review and regulatory filing collected for Tirzepatide, in one list. Each row links to the original. Nothing here is summarised for you — this is the corpus, source tag by source tag.

2,043 records · ordered by source hierarchy — human trials first, vendor material last

Corpus records for Tirzepatide
SourceKindRecordAttributionDetailDate
HUMAN-TRIALevidenceCost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.MounjaroWeight & fat loss · human-observational2026-12-01
HUMAN-TRIALevidenceAssociation of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study.TirzepatideGlycemic control · human-observational2026-08-01
HUMAN-TRIALevidenceShort-Term Combined Treatment With Tirzepatide and Metformin for Overweight/Obese Chinese Women With Polycystic Ovary Syndrome: A Prospective, Open-Label, Randomised Controlled Trial.TirzepatideWeight & fat loss · human-rct2026-08-01
HUMAN-TRIALevidenceEffect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.TirzepatideWeight & fat loss · human-rct2026-08-01
HUMAN-TRIALevidenceTirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO).TirzepatideGlycemic control · human-rct · n = 2062026-07-10
HUMAN-TRIALevidenceIxekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.TirzepatideWeight & fat loss · human-rct2026-07-01
HUMAN-TRIALevidenceApitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial.TirzepatideWeight & fat loss · human-rct2026-07-01
HUMAN-TRIALevidenceOrforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.TirzepatideWeight & fat loss · human-rct2026-07-01
HUMAN-TRIALevidenceTirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes : A Randomized Clinical Trial.TirzepatideGlycemic control · human-rct2026-07-01
HUMAN-TRIALevidenceA comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.TirzepatideGlycemic control · human-rct2026-07-01
HUMAN-TRIALevidenceSix-Month Real-World Effectiveness, Persistence and Safety of Low-to-Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study.TirzepatideWeight & fat loss · human-observational2026-07-01
HUMAN-TRIALevidenceRelationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.TirzepatideWeight & fat loss · human-rct2026-07-01
HUMAN-TRIALevidenceTirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety.TirzepatideWeight & fat loss · human-observational · n = 342026-07-01
HUMAN-TRIALevidenceTirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.TirzepatideWeight & fat loss · human-rct2026-06-06
HUMAN-TRIALevidenceEffects of testosterone undecanoate as add-on therapy in obese hypogonadal men that are late responders to tirzepatide: a pilot study.TirzepatideWeight & fat loss · human-observational · n = 102026-06-01
HUMAN-TRIALevidencePreoperative GLP-1 Receptor Agonists and Thromboinflammatory Markers in Patients Undergoing Abdominoplasty: A Prospective Monocentric Study.TirzepatideWeight & fat loss · human-observational2026-06-01
HUMAN-TRIALevidenceReal-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.TirzepatideGlycemic control · human-observational2026-06-01
HUMAN-TRIALevidenceShifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.TirzepatideWeight & fat loss · human-rct2026-06-01
HUMAN-TRIALevidenceGlucagon-Like Peptide-1 Receptor Agonist Utilization Among Sleep Surgery Clinic Patients.TirzepatideSleep quality · human-observational · n = 3842026-06-01
HUMAN-TRIALevidenceComparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort study.TirzepatideLipid & cardiovascular markers · human-observational · n = 8971822026-06-01
HUMAN-TRIALevidenceCardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial.TirzepatideGlycemic control · human-rct2026-06-01
HUMAN-TRIALevidenceGlucagon-like peptide-1 receptor agonists in patients with heart failure with reduced ejection fraction.TirzepatideLipid & cardiovascular markers · human-observational · n = 1270212026-05-05
HUMAN-TRIALevidenceShort-term effect of tirzepatide on serum calcitonin in adults with obesity.TirzepatideWeight & fat loss · human-observational2026-05-04
HUMAN-TRIALevidenceTirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study.TirzepatideCognition & memory · human-observational · n = 3350772026-05-01
HUMAN-TRIALevidenceGenetic predictors of GLP1 receptor agonist weight loss and side effects.TirzepatideWeight & fat loss · human-observational · n = 278852026-05-01
HUMAN-TRIALevidenceDose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting.TirzepatideGlycemic control · human-rct2026-05-01
HUMAN-TRIALevidenceEfficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.TirzepatideGlycemic control · human-rct2026-05-01
HUMAN-TRIALevidenceComparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study.TirzepatideGlycemic control · human-observational2026-05-01
HUMAN-TRIALevidenceA retrospective audit of weight loss and health outcomes following bariatric surgery at a tertiary public hospital.TirzepatideWeight & fat loss · human-observational · n = 2032026-05-01
HUMAN-TRIALevidenceMuscle atrophy associated with glucagon-like Peptide-1 receptor agonists: A population-based observational study.Tirzepatidehuman-observational2026-05-01
HUMAN-TRIALevidenceToward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical Practice.TirzepatideWeight & fat loss · human-observational2026-04-30
HUMAN-TRIALevidenceReal-world prescribing patterns and early weight and blood pressure outcomes of GLP-1-based therapies: a retrospective observational study in the United Arab Emirates.TirzepatideWeight & fat loss · human-observational2026-04-12
HUMAN-TRIALevidenceVarying Hypopnea Definitions and Treatment Eligibility in Obstructive Sleep Apnea.TirzepatideSleep quality · human-observational · n = 20572026-04-02
HUMAN-TRIALevidenceARD-101, a gut-restricted TAS2R agonist, reduces hunger in adults and promotes weight loss in DIO mice with DPP-4 inhibition.TirzepatideWeight & fat loss · human-rct2026-04-01
HUMAN-TRIALevidenceA treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.TirzepatideWeight & fat loss · human-observational2026-04-01
HUMAN-TRIALevidencePost hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease.Tirzepatidehuman-rct2026-04-01
HUMAN-TRIALevidenceEffectiveness and adherence in a tirzepatide-supported digital weight-loss programme in Australia: A real-world observational study.TirzepatideWeight & fat loss · human-observational2026-04-01
HUMAN-TRIALevidenceSafety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH.TirzepatideGlycemic control · human-rct2026-03-30
HUMAN-TRIALevidenceBispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial.TirzepatideGlycemic control · human-rct2026-03-24
HUMAN-TRIALevidenceWeight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials.TirzepatideWeight & fat loss · human-rct2026-03-02
HUMAN-TRIALevidenceEfficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT-1 Trial.TirzepatideWeight & fat loss · human-rct2026-03-01
HUMAN-TRIALevidencePsychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.TirzepatideWeight & fat loss · human-rct2026-03-01
HUMAN-TRIALevidenceA real-world study of tirzepatide for weight loss in adults without diabetes mellitus.TirzepatideWeight & fat loss · human-observational2026-03-01
HUMAN-TRIALevidenceSemaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world (STEER).TirzepatideWeight & fat loss · human-observational2026-03-01
HUMAN-TRIALevidence[SURPASS CVOT : cardiovascular benefits with tirzepatide versus dulaglutide in type 2 diabetes].TirzepatideGlycemic control · human-observational2026-03-01
HUMAN-TRIALevidenceTirzepatide and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial.TirzepatideWeight & fat loss · human-rct2026-03-01
HUMAN-TRIALevidenceGLP-1 receptor agonists reduce body mass index and total daily insulin dose in youth with type 1 diabetes: a retrospective cohort study.TirzepatideGlycemic control · human-observational2026-02-24
HUMAN-TRIALevidenceSemaglutide vs tirzepatide in patients with obesity and HFpEF: a report from a global federated research network.Tirzepatidehuman-observational2026-02-03
HUMAN-TRIALevidenceCardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial.TirzepatideWeight & fat loss · human-rct2026-02-01
HUMAN-TRIALevidenceAssociation of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial.TirzepatideWeight & fat loss · human-rct2026-02-01